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Abstract
Vitamin D is an essential nutrient and 
a secosteroid hormone that regulates 
many physiologic processes beyond 
calcium and bone homeostasis. These 
“extraskeletal” effects are impacted by the 
circulating levels of the storage form of 
vitamin D, 25-hydroxyvitamin D3. Levels 
of vitamin D can be detected after 
completing a simple 25(OH)D blood test. 
Vitamin D deficiency (<30 ng/mL) is 
associated with a higher risk of many 
chronic diseases including, but not limited 
to, fourteen types of cancers, type 1 and 
2 diabetes mellitus, obesity, 
cardiovascular disease, hypertension, 
stroke, and asthma. This article explores 
the association between vitamin D 
deficiency and the burden of chronic 
diseases in West Virginia.
Introduction
Vitamin D has well-established 
roles in calcium and bone 
homeostasis. Recently, this necessary 
nutrient has been shown to regulate 
many other disease and metabolic 
processes. These “extraskeletal” 
effects of vitamin D include potential 
beneficial effects on the prevention 
of cancer, obesity, diabetes, 
cardiovascular disease, stroke, and 
asthma. These diseases burden West 
Virginia with significant impact on 
morbidity and mortality (Table 1). 
Many variables affect these 
chronic diseases. West Virginia 
leads the nation in the following: 
current smokers (25.6%), limitation 
in physical activity (27.1%), 
insufficient sleep and rest (52.6%), 
and self reported poor health 
(25.8%).1 West Virginia ranks second 
in the nation for obesity (32.5%) 
and for percent of population > 65 
years of age.1-4 In addition, West 
Virginia has one of the lowest 
yearly solar irradiance rates in the 
country which affects the cutaneous 
synthesis of vitamin D (Figure 1). 5 
The principal mechanism for 
synthesis of the storage form of 
vitamin D, a potent fat-soluble 
secosteroid hormone, is skin 
exposure to sunlight, a mechanism 
that is less efficient with increasing 
age.6 Cutaneous production of 
vitamin D is dramatically altered 
by sunblock application (SPF 15; 
99% reduction in synthesis) and 
seasonal effects due to location 
with negligible production from 
mid-October to mid-March in West 
Virginia (Figure 2).6 Additionally, 
an increase in body mass index 
(BMI) decreases the bioavailability 
of fat-soluble vitamin D with a 1% 
increase in BMI associated with a 
5% decrease in serum vitamin D 
levels.6,7,8 As obesity increases in 
West Virginia, so does the risk of 
vitamin D deficiency. All of these 
factors (inactivity, obesity, location 
and age) make the risk of vitamin D 
deficiency greater for our population.
The storage form of vitamin D, 
25-hydroxyvitamin D3 or 25(OH)
D, can be determined with a simple 
blood test with deficiency defined 
Objectives
The objective of this article is to explore the association of vitamin D deficiency on major contributors to West Virginia disease 
morbidity and mortality.
Table 1. Important WV chronic diseases affected by Vitamin D levels.1
Disease (alphabetical) Prevalence in WV Vitamin D connection
Asthma 8.8% Yes
Cancer 10.4% Yes
Diabetes 12.4% (1st highest in US) Yes
Heart Disease 10.3% (1st highest in US) Yes
Hypertension 38.4% (2nd highest in US) Yes
Obesity 32.5% (2nd highest in US) Yes
Stroke 3.7% (3rd highest in US) Yes
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as less than 30 ng/mL.11 Vitamin D 
deficiency reportedly affects about 
50% US adults, with up to 54% 
deficiency prevalence noted among 
adolescent females.12-15 Because of 
increasing evidence linking vitamin 
D deficiency with chronic diseases, 
diagnosis and prevention beginning 
in childhood is paramount. 
The purpose of this review article 
is to use current data to explore 
the association between vitamin 
D deficiency and the burden of 
chronic diseases in West Virginia.
Normalcy
The human body uses about 
3000 to 5000 IU vitamin D3 per 
day.16 If cutaneous synthesis is 
altered (sunblock, season, age, skin 
coloration and disease states), it is 
very difficult to obtain this amount 
from a non-supplemented diet, even 
with a diet rich in fatty wild-caught 
fish.6,14,17 Because of this, numerous 
health care leaders have proposed 
a dramatic increase in the adequate 
intake of vitamin D over current 
recommendations.18 Many of the 
supplementation protocols used in 
studies cited in this manuscript have 
not accounted for the discrepancy 
in total daily use (4000-5000 IU/d) 
and recommended adequate 
intake (from 200 IU/d to 600IU/d; 
dependent on age and pregnancy) 
of vitamin D3. We therefore have 
placed more emphasis on studies 
that have conclusions based on 
direct testing of 25(OH)D and its 
impact on chronic diseases.
Cancer
The prevalence of cancer in West 
Virginians is 10.4%.1 Numerous 
studies have shown a correlation 
between 14 cancers, including 
colorectal, breast, and prostate, 
and vitamin D deficiency.19 Data 
is inconsistent regarding vitamin 
D supplementation and lowered 
cancer risk. For example, the 
Women’s Health Initiative showed 
supplementing 400 IU of vitamin 
D3 combined with 1000 mg 
calcium daily to have no effect on 
the incidence of colorectal cancer 
or breast cancer.20,21 Lappe et al. 
showed a significant reduction in 
all-cancer risk for women taking 
1100 IU of vitamin D3 and 1500 mg 
of calcium supplementation.22 The 
direction of association is dependent 
on sufficient levels of 25(OH)D. 
Figure 1.
United States Solar Irradiance Map. The average yearly solar irradiance in Watt/hr is 
demonstrated. West Virginia has one of the lowest rates in the contiguous US. Source: 
National Renewable Energy Laboratory.3 Available at http://www.nrel.gov/gis/solar.html
Figure 2.
37th Parallel and effect on vitamin D production. West Virginia is above the 37th 
parallel resulting in negligible cutaneous production of vitamin D from mid-October 
to mid-March. When the leaves are falling, so are 25(OH)D levels. There is a direct 
correlation with vitamin D deficiency and distance from the equator.9,10
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Cancer risk is decreased when 
levels of 25(OH)D are at least 32 ng/
mL.23 Gorham et al., demonstrated 
a 50% reduction in colorectal cancer 
risk at 33 ng/mL 25(OH)D with a 
World Health Organization (WHO) 
working group identifying colon 
cancer as the greatest risk associated 
with poor vitamin D status.24 Garland 
et al., showed a 50% reduction in 
breast cancer risk at 52 ng/mL 
25(OH)D.25 In general, the levels 
of circulating 25(OH)D needed to 
reduce cancer risk in the population 
are much higher than current vitamin 
D adequate intake recommendations. 
Cardiovascular disease 
(CVD), Hypertension, Stroke 
West Virginia has the highest 
rate of cardiovascular disease in 
the US; 10.3% of our population 
has symptomatic coronary artery 
disease.1 The mechanisms in which 
vitamin D may lower cardiovascular 
risk have not been fully elucidated, 
but many possible mechanisms have 
been proposed. For hypertension, 
the renin-angiotensin-aldosterone 
system (RAAS) appears to be 
suppressed by vitamin D with the 
risk of hypertension increasing 
from south to north in the Northern 
hemisphere.26,27 Thus, a deficiency 
may lead to hypertension, a risk 
factor for CVD. Deficiency of 
vitamin D is associated with poor 
glycemic control28, another risk 
factor for CVD. The presence of 
vitamin D decreases inflammatory 
markers and even increases anti-
inflammatory markers, each of which 
is beneficial to the cardiovascular 
system.29,30 Vascular smooth muscle 
and endothelium responds to 
vitamin D in a cardioprotective 
way by decreasing smooth muscle 
cell proliferation31, inflammation16, 
and thrombosis.33 Each of these 
is a risk factor for cardiovascular 
disease. Unfortunately, adequate 
clinical trials looking at vitamin D 
supplementation with cardiovascular 
endpoints are lacking. The 
Framingham Offspring Study 
demonstrated an 80% greater risk 
for cardiovascular disease when 
vitamin D levels were less than 10 
ng/mL compared to participants 
with a 25(OH)D level greater than 
15 ng/mL.34 Both the Nurse’s Health 
Study and the Health Professionals 
Follow-up Study found an increased 
incidence of hypertension when 
25(OH)D levels were below 15 ng/mL 
compared to levels above 30 ng/mL.35 
A more recent study showed post-
menopausal women with 25(OH)D3 
levels <20 ng/mL to have increased 
cardiovascular risk factors as well as 
an increased risk of cardiovascular 
disease, cerebrovascular disease, 
and death when compared to the 
non-deficient (>20 ng/mL 25(OH)
D3) group. Another recent study, 
which followed suspected acute 
coronary syndrome patients 
for 2 years, reported an inverse 
relationship with death within that 
2 year period and vitamin D status. 
Clearly, vitamin D plays a role in the 
health of the vascular system, but 
research to determine the optimal 
level of vitamin D and the role of 
supplementation is needed.36 
Clinical trials examining the effect 
of Vitamin D supplementation on 
blood pressure have variable results. 
One meta-analysis of 8 clinical trials 
demonstrated a significant 3.1 mmHg 
reduction in the diastolic pressure 
with a non-significant 3.6 mmHg 
reduction in systolic pressure when 
vitamin D was supplemented.37 
Another meta-analysis of 10 trials 
found that most did not show 
statistically significant effects on 
blood pressure.38 Meta-analysis 
of trials investigating the effects 
of vitamin D supplementation on 
cardiovascular outcomes, including 
myocardial infarction, stroke, and 
other cardiac and cerebral outcomes 
showed no statistically significant 
effects.38 Trials performed to date, 
however, have significant variation 
in the vitamin D levels that were 
used to define insufficiency, 
measured outcomes, doses used, 
and identified confounders.38 
Multiple studies have 
demonstrated an association 
between vitamin D insufficiency 
and cerebrovascular disease 
mortality with one recent study 
showing twice the risk of stroke 
from lowest (<9.8 ng/mL 25(OH)
D) to highest quartile (>21.5 ng/
mL 25(OH)D).39,40,41 Carrelli et al. 
found a correlation between carotid 
atherosclerosis, a major risk factor 
for stroke, and 25(OH)D status.42 A 
population-based study found data 
that suggests a reduced intake of 
vitamin D in elderly patients, along 
with low serum concentrations of 
1,25-dihydroxyvitamin D, leads 
to an increased risk for future 
strokes.43 With numerous studies 
revealing an association between 
vitamin D status and cerebrovascular 
risk, future research should be 
directed at determining whether a 
causal relationship exists through 
clinical supplementation trials.
Asthma
Asthma is a chronic inflammatory 
airway disease caused by a 
combination of environmental and 
genetic factors. In recent years, the 
prevalence of children with asthma 
was significantly higher in WV than 
the nation as a whole. According 
to a CDC report based on 2009 
data, around 9% of West Virginians 
carried a diagnosis of asthma.1 
With such a strong prevalence, it 
is crucial to continually seek new 
methods to treat and reduce the 
incidence of this common disease. 
Vitamin D receptors are located 
in multiple lung cell types and have 
beneficial effects on asthma control. 
Several mechanisms are used to 
promote these effects including 
reducing hyperplasia and airway 
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smooth muscle proliferation, 
decreasing inflammation, promoting 
lung immunity, slowing cell 
cycling, and enhancing the effects of 
exogenous steroids.44,45 An inverse 
relationship between vitamin D 
status and serum IgE levels was 
demonstrated by Ma and Zhen.46 
This supports the idea that vitamin 
D deficiency is related to increased 
risk of asthma and allergy.47 A study 
by Alyasin et al. in 2011 showed that 
serum 25(OH)D levels were inversely 
associated with asthma.48 This was a 
cross-sectional study conducted with 
children and, after adjusting for age, 
BMI, and sex, the correlation between 
vitamin D and asthma increased. 
The study also found a significant 
relationship between pulmonary 
function test outcomes, such as FEV1 
and FEV1/FRC, and vitamin D levels. 
Similarly, a case control study by 
Ehlayel et al. in 2011 suggested a link 
between vitamin D deficiency and 
development of asthma and allergic 
diseases.49 Vitamin D levels were 
lower in asthmatic children than in 
control subjects.49 Furthermore, a 
Chinese case-control cohort study 
revealed that genetic polymorphisms 
of vitamin D binding protein increase 
the susceptibility of asthma within 
the Chinese Han population.50 
Searing et al. demonstrated in vitro 
that vitamin D can enhance the action 
of glucocorticoids on inflammation.51 
Thus, correction of vitamin D 
deficiency, which is often associated 
with asthma, could be a possible 
therapeutic option for glucocorticoid 
resistant asthma. The exact role 
25(OH)D plays on the pathogenesis 
of asthma is still under investigation, 
but a significant correlation has 
been made to higher serum levels of 
vitamin D and reduction of asthma. 
Diabetes and Metabolic 
Syndrome
West Virginia ranks among the 
highest in the nation for prevalence 
of diabetes with estimates for adults 
approximately 12.4%.1 West Virginia 
also ranks second nationally for 
obesity rates with a prevalence of 
32.5%.1 Several studies show an 
inverse relationship between BMI 
and concentrations of 25(OH)D.7,8 
Because vitamin D is fat soluble, 
it is readily taken up by fat cells, 
and this sequestration of vitamin 
D likely plays a large role in its 
decreased bioavailability.8 Decreased 
levels of 25(OH)D associated with 
higher BMI may play a key role in 
insulin resistance and thus type-2 
diabetes in metabolic syndrome. 
Research in this area is relatively 
new, and there are some conflicting 
findings. One analysis showed 
an association between higher 
vitamin D concentrations and a 
reduced risk for developing type 
2 diabetes mellitus in men only.52 
Chiu et al. found increased risk for 
metabolic syndrome with lower 
25(OH)D levels.28 Additionally, 
they found that vitamin D is 
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directly associated with insulin 
sensitivity and release from beta-
cells.28 Unfortunately, randomized 
trials investigating the effects of 
vitamin D supplementation have 
failed to consistently demonstrate a 
beneficial effect on insulin resistance 
or insulin secretion.53 Most of these 
studies were very short in duration 
(4 days to 2 years), which may not 
be long enough to show clinically 
significant beneficial effects.
Vitamin D receptors are present in 
activated T and B-lymphocytes and in 
activated macrophages, which make 
up a portion of our immune response. 
Mouse models were used to show 
that reduction in the incidence of type 
1 diabetes was achieved if the mice 
received 1,25(OH)2D3 early in life.54 
Of note, the autocrine production of 
the locally active form of vitamin D, 
1,25(OH)2D3, is critically dependent 
on adequate concentration of 25(OH)
D.55 Another study in by Hyppönen 
et al. followed a cohort of children 
for the first 31 years of life. They 
observed that children who received 
2000 IU vitamin D during their 
first year of life decreased their 
risk of developing type 1 diabetes 
by 78% compared to children who 
did not receive supplementation.56 
A meta-analysis by Zipitis and 
Akobeng demonstrated significant 
reduction in the incidence of type 1 
diabetes with supplementation of 
vitamin D in the first year of life.57 
Follow-up studies are needed to 
establish the best treatment regimen 
for vitamin D supplementation. 
Vitamin D Levels for 
Extraskeletal Benefit
Currently, vitamin D intake 
recommendations are based solely 
on bone health and do not consider 
the potential extraskeletal benefits 
of higher vitamin D levels. Bischoff-
Ferrari et al. suggested target 
concentrations of at least 30 ng/mL, 
with ideal levels of 25(OH)D around 
36-40 ng/mL.58 They also estimated 
that to bring half the population to 
the ideal concentration of 25(OH)D, 
daily intake between 700 and 1000 
IU of vitamin D would be required.58 
Lappe, however, estimated optimal 
levels of 25(OH)D to be as low as 
30-32 ng/mL.55 Heaney projected that 
supplementing the entire population 
with 2000 IU/day of vitamin D3 
would result in at least 80% of the 
population having a 25(OH)D level 
greater than 32 ng/mL.59 Daily 
intake and production of vitamin D 
varies widely with age, BMI, outdoor 
activity level, sunblock use, various 
disease states (e.g. kidney or liver 
disease preventing key hydroxylation 
reactions), time of the year, and 
latitude.6 The only way to diagnose 
and safely treat vitamin D deficiency 
is to measure serum 25(OH)D. 
Unfortunately, insurance coverage 
for measurement is limited.55 
Current indications for obtaining 
25(OH)D levels are listed in Table 2. 
Laboratory testing reimbursement 
can occur up to 4 times per annum 
with levels determined following 
supplementation protocols to 
correct vitamin D deficiency.
There are three ways to impact 
vitamin D stores: sun exposure, diet 
or supplementation. In people with 
light skin coloration, sun exposure 
below the minimal erythemal dose 
(skin redness) is usually enough 
to make sufficient daily vitamin 
D requirements. This is typically 
about 10 minutes during the day 
from 10:00 am to 3:00 pm without 
sunscreen and with minimal 
clothing (i.e. swimsuit).55 However, 
at latitudes above 37 degrees North, 
from mid-October to mid-March, 
no vitamin D is made cutaneously 
due to the steep solar angle.55 
(Figure 2) Current public sensitivity 
connected to sun exposure is worth 
noting. Early studies demonstrated 
that skin cancer rates increased 
with sun exposure, however, 
non-skin cancer rates actually 
decreased.60,61,62 Additionally, one 
should emphasize that many of our 
vital processes have an evolutionary 
dependence on sun exposure 
and vitamin D production (e.g. 
immunity) with over 20 photoactive 
products produced cutaneously 
following sun exposure.6,63 The 
ultimate effect of blocking normal 
cutaneous photoproduct synthesis 
with sunblock is not known.
Table 2. Indications for 25(OH)D Testing that may be eligible for Medicare 
Reimbursement.55  
Disorders of parathyroid gland Other hyperparathyroidism
Hypoparathyroidism Rickets, active
Osteomalacia, unspecified Unspecified vitamin D deficiency
Disorders of phosphorus metabolism Disorders of calcium metabolism
Chronic kidney disease (CKD) Secondary hyperparathyroidism (of renal origin)
Osteoporosis Other osteoporosis
Disorder of bone and cartilage, 
unspecified Paget’s Disease
History or risk of falls Fibromyalgia
Malabsorption syndrome History of bariatric surgery
Liver Disease Anticonvulsant use
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The second way to alter vitamin D 
status is through diet. Many foods are 
fortified with vitamin D, and foods 
such as wild-caught salmon, tuna, 
cod liver oil, and beef liver naturally 
contain vitamin D. However, 
NHANES III data demonstrate that 
diet supplies very little of the 4000 to 
5000 IU of vitamin D3 used per day.15 
The third way to affect vitamin 
D status is supplementation. One 
should know that both D2 (plant) 
and D3 (animal) are available 
over the counter with D3 more 
effective in raising 25(OH)D 
levels.64,65 We recommend following 
current recommendations for 
supplementation and testing 
protocols as highlighted in the 
New England Journal of Medicine.6 
Conclusion
Vitamin D receptors are located 
in many cell types throughout 
the body, and vitamin D plays a 
regulatory role in many physiologic 
processes. Low levels of the storage 
form of vitamin D, 25(OH)D, are 
correlated with higher risk of many 
diseases including, but not limited to, 
asthma, cancer, type 1 and 2 diabetes 
mellitus, obesity and metabolic 
syndrome, cardiovascular disease, 
hypertension, and cerebrovascular 
disease. These diseases in particular 
have a high prevalence in West 
Virginia as well as the U.S. With the 
current epidemic of hypovitaminosis 
D, it is essential to test for and 
correct this modifiable risk factor 
by educating patients about 
appropriate sun exposure, proper 
nutrition, availability, and proper 
usage of vitamin D supplements.
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